---
figid: PMC8067156__marinedrugs-19-00196-g002
figtitle: Pathophysiology of Ulcerative Colitis
organisms:
- NA
pmcid: PMC8067156
filename: marinedrugs-19-00196-g002.jpg
figlink: pmc/articles/PMC8067156/figure/marinedrugs-19-00196-f002/
number: F2
caption: 'Pathophysiology of Ulcerative Colitis. Impairment of tight junctions and
  the mucous layer leads to increased permeability of the intestinal epithelium, resulting
  in more uptake of luminal antigens. Antigen presenting cells (APC) become activated
  upon recognizing non-pathogenic bacteria (commensal microbiota) through Toll-like
  receptors (TLRs). Activated APC initiate differentiation of naïve CD4+ T-cells into
  Th-2 effector cells (which produce pro-inflammatory cytokines such as TNF-α, IL-5,
  IL-6, and IL-13). TNF-α and IL-1 activate nuclear factor κB (NF-κB) pathway, which
  facilitate expression of pro-inflammatory and cell survival genes. Binding of integrin-α4β7
  bearing T cells to the mucosal adhesion molecule MAdCAM-1 facilitate entry of more
  T cells into the lamina propria. Recruitment of circulating leucocytes due to the
  upregulation of inflammatory chemokines (chemokine ligands: CXCL1, CXCL3, CXCL8
  and CXCL10) perpetuates the inflammatory cycle. MAdCAM-1, mucosal addressin cell
  adhesion molecule-1; IL, interleukin; TNF-α, tumor necrosis factor-alpha; TGF-β,
  transforming growth factor-beta; NKT, natural killer T; DC, dendritic cell; Th,
  T helper; GATA3, GATA binding protein 3; IRF4, interferon regulatory factor 4; PU.1,
  purine-rich PU-box binding protein; FOXP3, Forkhead box protein 3. Reprinted from
  Ref. [] with permission under the Creative Commons Attribution (CC BY) license.
  Copyright © 2020 the authors. Licensee MDPI, Basel, Switzerland.'
papertitle: Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory
  Bowel Disease.
reftext: Muhammad Bilal, et al. Mar Drugs. 2021 Apr;19(4):196.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.954035
figid_alias: PMC8067156__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8067156__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8067156__marinedrugs-19-00196-g002.html
  '@type': Dataset
  description: 'Pathophysiology of Ulcerative Colitis. Impairment of tight junctions
    and the mucous layer leads to increased permeability of the intestinal epithelium,
    resulting in more uptake of luminal antigens. Antigen presenting cells (APC) become
    activated upon recognizing non-pathogenic bacteria (commensal microbiota) through
    Toll-like receptors (TLRs). Activated APC initiate differentiation of naïve CD4+
    T-cells into Th-2 effector cells (which produce pro-inflammatory cytokines such
    as TNF-α, IL-5, IL-6, and IL-13). TNF-α and IL-1 activate nuclear factor κB (NF-κB)
    pathway, which facilitate expression of pro-inflammatory and cell survival genes.
    Binding of integrin-α4β7 bearing T cells to the mucosal adhesion molecule MAdCAM-1
    facilitate entry of more T cells into the lamina propria. Recruitment of circulating
    leucocytes due to the upregulation of inflammatory chemokines (chemokine ligands:
    CXCL1, CXCL3, CXCL8 and CXCL10) perpetuates the inflammatory cycle. MAdCAM-1,
    mucosal addressin cell adhesion molecule-1; IL, interleukin; TNF-α, tumor necrosis
    factor-alpha; TGF-β, transforming growth factor-beta; NKT, natural killer T; DC,
    dendritic cell; Th, T helper; GATA3, GATA binding protein 3; IRF4, interferon
    regulatory factor 4; PU.1, purine-rich PU-box binding protein; FOXP3, Forkhead
    box protein 3. Reprinted from Ref. [] with permission under the Creative Commons
    Attribution (CC BY) license. Copyright © 2020 the authors. Licensee MDPI, Basel,
    Switzerland.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - GATA3
  - IL13
  - IL5
  - IL4
  - IL2
  - TGFB1
  - TGFB2
  - TGFB3
  - IRF4
  - SPI1
  - CD4
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - IL1B
  - IL6
  - IL12A
  - IL12B
  - IL37
  - IL23A
  - FOXP3
  - IL10
  - TNF
  - CXCL10
  - CXCL1
  - CXCL3
  - CXCL8
  - Retinoic acid
  - inflammation
---
